Special Explanation on Non-Operating Fund Occupation and Other Related Fund Transactions
To: All shareholders of Beijing Saisheng Pharmaceutical Co., Ltd.
We have accepted the commission from Beijing Saisheng Pharmaceutical Co., Ltd. (hereinafter referred to as "Saisheng Pharmaceutical") to audit the consolidated and company balance sheets as of December 31, 2025, the consolidated and company income statements, consolidated and company cash flow statements, consolidated and company statements of changes in shareholders' equity, and the notes to the financial statements, in accordance with the Chinese Certified Public Accountant Practice Standards. We issued an unqualified audit report (Zhi Tong Audit Report No. 110A006327) for the year 2025.